Skip to main content
Erschienen in: Rheumatology International 4/2003

01.07.2003 | Original Article

Detecting abnormal regional cerebral blood flow in patients with primary Sjögren's syndrome by technetium-99m ethyl cysteinate dimer single photon emission computed tomography of the brain—a preliminary report

verfasst von: W. S. Huang, P. Y. Chiu, A. Kao, C. H. Tsai, C. C. Lee

Erschienen in: Rheumatology International | Ausgabe 4/2003

Einloggen, um Zugang zu erhalten

Abstract

Technetium-99m ethyl cysteinate dimer (Tc-99m ECD) brain single photon emission computed tomography (SPECT) was used to detect abnormal regional cerebral blood flow (rCBF) in 32 female patients with primary Sjögren's syndrome (PSS) showing definite neuropsychiatric symptoms/signs and normal brain magnetic resonance imaging (MRI) findings. It demonstrated hypoperfusion brain lesions in 18 (56.3%) of the patients, most frequently in the parietal lobes, and appears to be a sensitive tool for this clinical application.
Literatur
1.
Zurück zum Zitat Alexander E (1992) Central nervous system disease in Sjögren's syndrome: new insights into immunopathogenesis. Rheum Dis Clin North Am 18:637–672PubMed Alexander E (1992) Central nervous system disease in Sjögren's syndrome: new insights into immunopathogenesis. Rheum Dis Clin North Am 18:637–672PubMed
2.
Zurück zum Zitat Farnam J, Jorizzo JL, Grant JA, Lavastida MT, Ichikawa Y, Daniels JC (1984) Sjögren's syndrome presenting with hypereosinophilia, lymphopenia and circulating immune complexes. Clin Exp Rheumatol 2:41–46 Farnam J, Jorizzo JL, Grant JA, Lavastida MT, Ichikawa Y, Daniels JC (1984) Sjögren's syndrome presenting with hypereosinophilia, lymphopenia and circulating immune complexes. Clin Exp Rheumatol 2:41–46
3.
Zurück zum Zitat Fox RI, Howell FV, Bone RC, Michelson P (1984) Primary Sjögren's syndrome: clinical and immunopathological features. Semin Arthritis Rheum 14:77–105PubMed Fox RI, Howell FV, Bone RC, Michelson P (1984) Primary Sjögren's syndrome: clinical and immunopathological features. Semin Arthritis Rheum 14:77–105PubMed
4.
Zurück zum Zitat Sjögren H (1935) Zur Kenntnis der Keratoconjunctivitis Sicca II. Allgemeine Symptomatologie und Ätiologie. Acta Opthalmol (Kbh) 13:1–39 Sjögren H (1935) Zur Kenntnis der Keratoconjunctivitis Sicca II. Allgemeine Symptomatologie und Ätiologie. Acta Opthalmol (Kbh) 13:1–39
5.
Zurück zum Zitat Hietaharju A, Yli-Kerttula U, Hakkinen V, Frey H (1990) Nervous system manifestations in Sjögren's syndrome. Acta Neurol Scand 81:144–152PubMed Hietaharju A, Yli-Kerttula U, Hakkinen V, Frey H (1990) Nervous system manifestations in Sjögren's syndrome. Acta Neurol Scand 81:144–152PubMed
6.
Zurück zum Zitat Alexander EL, Beall S, Provost TT (1989) Magnetic resonance imaging (MRI) in primary Sjögren's syndrome with central nervous system disease (CNS-SS): new clues to pathogenesis. Arthritis Rheum 29:S63 Alexander EL, Beall S, Provost TT (1989) Magnetic resonance imaging (MRI) in primary Sjögren's syndrome with central nervous system disease (CNS-SS): new clues to pathogenesis. Arthritis Rheum 29:S63
7.
Zurück zum Zitat Manthorpe R, Manthorpe T, Sjoberg S (1992) Magnetic resonance imaging of the brain in patients with primary Sjögren's syndrome. Scand J Rheumatol 21:148–149PubMed Manthorpe R, Manthorpe T, Sjoberg S (1992) Magnetic resonance imaging of the brain in patients with primary Sjögren's syndrome. Scand J Rheumatol 21:148–149PubMed
8.
Zurück zum Zitat Moutsopoulos HM, Sarmas JH, Talal N (1993) Is central nervous system involvement a systemic manifestation of primary Sjögren's syndrome? Rheum Dis Clin North Am 19:909–912PubMed Moutsopoulos HM, Sarmas JH, Talal N (1993) Is central nervous system involvement a systemic manifestation of primary Sjögren's syndrome? Rheum Dis Clin North Am 19:909–912PubMed
9.
Zurück zum Zitat Kao CH, Lan JL, ChangLai SP, Chieng PU (1998) Technetium-99m-HMPAO brain SPECT in Sjögren's syndrome. J Nucl Med 39:773–777PubMed Kao CH, Lan JL, ChangLai SP, Chieng PU (1998) Technetium-99m-HMPAO brain SPECT in Sjögren's syndrome. J Nucl Med 39:773–777PubMed
10.
Zurück zum Zitat Neirinckx RD, Canning LR, Piper IM, Nowotnik DP, Pickett RD, Holmes RA, Volkert WA, Forster AM, Weisner PS, Marriott JA (1987) Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 28:191–202 Neirinckx RD, Canning LR, Piper IM, Nowotnik DP, Pickett RD, Holmes RA, Volkert WA, Forster AM, Weisner PS, Marriott JA (1987) Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion. J Nucl Med 28:191–202
11.
Zurück zum Zitat Juni JE, Waxman AD, Devous MD Sr, Tikofsky RS, Ichise M, Van Heertum RL, Holman BL, Carretta RF, Chen CC (1998) Procedure guideline for brain perfusion SPECT using technetium-99m radiopharmaceuticals. J Nucl Med 39:923–926PubMed Juni JE, Waxman AD, Devous MD Sr, Tikofsky RS, Ichise M, Van Heertum RL, Holman BL, Carretta RF, Chen CC (1998) Procedure guideline for brain perfusion SPECT using technetium-99m radiopharmaceuticals. J Nucl Med 39:923–926PubMed
12.
Zurück zum Zitat Leveille J, Demonceau G, De Roo M, Rigo P, Taillefer R, Morgan RA, Kupranick D, Walovitch RC (1989) Characterization of Tc-99m-L,L-ECD for brain perfusion. Part 2. Biodistribution and brain imaging in humans. J Nucl Med 30:1902–1910PubMed Leveille J, Demonceau G, De Roo M, Rigo P, Taillefer R, Morgan RA, Kupranick D, Walovitch RC (1989) Characterization of Tc-99m-L,L-ECD for brain perfusion. Part 2. Biodistribution and brain imaging in humans. J Nucl Med 30:1902–1910PubMed
13.
Zurück zum Zitat Asenbaum S, Brucke T, Pirker W, Pietrzyk U, Podreka I (1998) Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison. J Nucl Med 39:613–618PubMed Asenbaum S, Brucke T, Pirker W, Pietrzyk U, Podreka I (1998) Imaging of cerebral blood flow with technetium-99m-HMPAO and technetium-99m-ECD: a comparison. J Nucl Med 39:613–618PubMed
14.
Zurück zum Zitat Koyama M, Kawashima R, Ito H, Ono S, Sato K, Goto R, Kinomura S, Yoshioka S, Sato T, Fukuda H (1997) SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD. J Nucl Med 38:587–592PubMed Koyama M, Kawashima R, Ito H, Ono S, Sato K, Goto R, Kinomura S, Yoshioka S, Sato T, Fukuda H (1997) SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD. J Nucl Med 38:587–592PubMed
15.
Zurück zum Zitat van Dyck CH, Lin CH, Smith EO, Wisniewski G, Cellar J, Robinson R, Narayan M, Bennett A, Delaney RC, Bronen RA, Hoffer PB (1996) Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease. J Nucl Med 37:1749–1755PubMed van Dyck CH, Lin CH, Smith EO, Wisniewski G, Cellar J, Robinson R, Narayan M, Bennett A, Delaney RC, Bronen RA, Hoffer PB (1996) Comparison of technetium-99m-HMPAO and technetium-99m-ECD cerebral SPECT images in Alzheimer's disease. J Nucl Med 37:1749–1755PubMed
16.
Zurück zum Zitat Leveille J, Demonceau G, Walovitch RC (1992) Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects. J Nucl Med 33:480–484PubMed Leveille J, Demonceau G, Walovitch RC (1992) Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects. J Nucl Med 33:480–484PubMed
17.
Zurück zum Zitat Kuwabara Y, Ichiya Y, Otsuka M, Tahara T, Fukumura T, Gunasekera R, Masuda K (1990) Differential diagnosis of bilateral parietal abnormalities in I-123 IMP SPECT imaging. Clin Nucl Med 15:893–899 Kuwabara Y, Ichiya Y, Otsuka M, Tahara T, Fukumura T, Gunasekera R, Masuda K (1990) Differential diagnosis of bilateral parietal abnormalities in I-123 IMP SPECT imaging. Clin Nucl Med 15:893–899
18.
Zurück zum Zitat DeVolder AG, Goffinet AM, Bol A, Michel C, de-Barsy T, Laterre C (1990) Brain glucose metabolism in postanoxic syndrome. Positron emission tomographic study. Arch Neurol 47:197–204PubMed DeVolder AG, Goffinet AM, Bol A, Michel C, de-Barsy T, Laterre C (1990) Brain glucose metabolism in postanoxic syndrome. Positron emission tomographic study. Arch Neurol 47:197–204PubMed
19.
Zurück zum Zitat Devinsky O, Petito CK, Alonso DR (1988) Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli and thrombotic thrombocytopenia purpura. Ann Neurol 23:380–384 Devinsky O, Petito CK, Alonso DR (1988) Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis, heart emboli and thrombotic thrombocytopenia purpura. Ann Neurol 23:380–384
20.
Zurück zum Zitat Nishimura H, Tachibana H, Makiura N, Okuda B, Sugita M (1994) Corticosteroid-responsive parkinsonism associated with primary Sjögren's syndrome. Clin Neurol Neurosurg 96:327–331PubMed Nishimura H, Tachibana H, Makiura N, Okuda B, Sugita M (1994) Corticosteroid-responsive parkinsonism associated with primary Sjögren's syndrome. Clin Neurol Neurosurg 96:327–331PubMed
21.
Zurück zum Zitat Gerraty RP, McKelvie PA, Byrne E (1993) Aseptic meningoencephalitis in primary Sjögren's syndrome. Response to plasmapheresis and absence of CNS vasculitis at autopsy. Acta Neurol Scand 88:309–311PubMed Gerraty RP, McKelvie PA, Byrne E (1993) Aseptic meningoencephalitis in primary Sjögren's syndrome. Response to plasmapheresis and absence of CNS vasculitis at autopsy. Acta Neurol Scand 88:309–311PubMed
22.
Zurück zum Zitat Berman JL, Kashii S, Trachtman MS, Burde RM (1990) Optic neuropathy and central nervous system disease secondary to Sjögren's syndrome in a child. Ophthalmology 97:1606–1609PubMed Berman JL, Kashii S, Trachtman MS, Burde RM (1990) Optic neuropathy and central nervous system disease secondary to Sjögren's syndrome in a child. Ophthalmology 97:1606–1609PubMed
23.
Zurück zum Zitat de la Monte SM, Hutchins GM, Gupta PK (1983) Polymorphous meningitis with atypical mononuclear cells in Sjögren's syndrome. Ann Neurol 14:455–461 de la Monte SM, Hutchins GM, Gupta PK (1983) Polymorphous meningitis with atypical mononuclear cells in Sjögren's syndrome. Ann Neurol 14:455–461
24.
Zurück zum Zitat Alexander EL, Provost TT, Stevens MB, Alexander GE (1982) Neurologic complications of primary Sjögren's syndrome. Medicine 61:247–257 Alexander EL, Provost TT, Stevens MB, Alexander GE (1982) Neurologic complications of primary Sjögren's syndrome. Medicine 61:247–257
Metadaten
Titel
Detecting abnormal regional cerebral blood flow in patients with primary Sjögren's syndrome by technetium-99m ethyl cysteinate dimer single photon emission computed tomography of the brain—a preliminary report
verfasst von
W. S. Huang
P. Y. Chiu
A. Kao
C. H. Tsai
C. C. Lee
Publikationsdatum
01.07.2003
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 4/2003
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-002-0272-1

Weitere Artikel der Ausgabe 4/2003

Rheumatology International 4/2003 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.